These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 35639233

  • 1. Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: emphasis on Sirt1/Nrf2 signaling pathway.
    Ibrahim WW, Abdel Rasheed NO.
    Inflammopharmacology; 2022 Oct; 30(5):1745-1758. PubMed ID: 35639233
    [Abstract] [Full Text] [Related]

  • 2. Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: Cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway.
    Abdel Rasheed NO, Ibrahim WW.
    Life Sci; 2022 May 15; 297():120480. PubMed ID: 35278421
    [Abstract] [Full Text] [Related]

  • 3. Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway.
    El-Shamarka ME, El-Sahar AE, Saad MA, Assaf N, Sayed RH.
    Life Sci; 2022 Jul 01; 300():120569. PubMed ID: 35472453
    [Abstract] [Full Text] [Related]

  • 4. Parthenolide ameliorates 3-nitropropionic acid-induced Huntington's disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting.
    Noureldeen ME, Shahin NN, Amin HAA, El-Sawalhi MM, Ghaiad HR.
    Mol Med; 2024 Sep 26; 30(1):158. PubMed ID: 39327568
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway.
    Gopinath K, Sudhandiran G.
    Neuroscience; 2012 Dec 27; 227():134-43. PubMed ID: 22871521
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease.
    Gao Y, Chu SF, Li JP, Zhang Z, Yan JQ, Wen ZL, Xia CY, Mou Z, Wang ZZ, He WB, Guo XF, Wei GN, Chen NH.
    Acta Pharmacol Sin; 2015 Mar 27; 36(3):311-22. PubMed ID: 25640478
    [Abstract] [Full Text] [Related]

  • 14. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
    Colle D, Santos DB, Moreira EL, Hartwig JM, dos Santos AA, Zimmermann LT, Hort MA, Farina M.
    PLoS One; 2013 Mar 27; 8(6):e67658. PubMed ID: 23799154
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
    Suganya SN, Sumathi T.
    Metab Brain Dis; 2017 Apr 27; 32(2):471-481. PubMed ID: 27928694
    [Abstract] [Full Text] [Related]

  • 17. ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.
    Hanna DM, Tadros MG, Khalifa AE.
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul 03; 60():36-51. PubMed ID: 25689821
    [Abstract] [Full Text] [Related]

  • 18. Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington's disease like symptoms in rats.
    Salman M, Sharma P, Alam MI, Tabassum H, Parvez S.
    Nutr Neurosci; 2022 Sep 03; 25(9):1898-1908. PubMed ID: 33856270
    [Abstract] [Full Text] [Related]

  • 19. Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.
    Ramachandran S, Thangarajan S.
    Metab Brain Dis; 2018 Oct 03; 33(5):1459-1470. PubMed ID: 29855977
    [Abstract] [Full Text] [Related]

  • 20. Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK.
    Habib MZ, Tadros MG, Abd-Alkhalek HA, Mohamad MI, Eid DM, Hassan FE, Elhelaly H, Faramawy YE, Aboul-Fotouh S.
    Eur J Pharmacol; 2022 Jul 15; 927():175046. PubMed ID: 35623405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.